These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3307130)

  • 1. A simple hemolytic assay for bovine complement component C3.
    Mhatre A; Aston WP
    Vet Immunol Immunopathol; 1987 Jun; 15(3):239-51. PubMed ID: 3307130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple alternative pathway for hemolytic assay of human complement component C3 using methylamine-treated plasma.
    Jessen TE; Barkholt V; Welinder KG
    J Immunol Methods; 1983 May; 60(1-2):89-100. PubMed ID: 6406606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolytic plate assay for quantification of active human complement component C3 using methylamine-treated plasma as complement source.
    Ploug M; Jessen TE; Welinder KG; Barkholt V
    Anal Biochem; 1985 May; 146(2):411-7. PubMed ID: 3927773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of an R3 reagent (serum depleted of the third component of human complement (C3)) by immunoadsorption. Application to the hemolytic assay of human C3.
    Fontaine M; Joisel F; Dumouchel L
    J Immunol Methods; 1980; 33(2):145-58. PubMed ID: 6989915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity.
    Ebanks RO; Isenman DE
    Mol Immunol; 1996 Feb; 33(3):297-309. PubMed ID: 8649451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of the fifth component of the bovine complement system.
    Aston WP; Mhatre A; Macrae J
    Vet Immunol Immunopathol; 1990 Apr; 24(4):301-12. PubMed ID: 2140216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C3-like activity in C3-deficient dog serum.
    Johnson JP
    Complement; 1987; 4(1):53-60. PubMed ID: 3105954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1981 Sep; 154(3):856-67. PubMed ID: 6912277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A one-step procedure for preparation of classical pathway (C1q) and alternative pathway (factor D) depleted human serum.
    Praz F; Roque Antunes Barreira MC; Lesavre P
    J Immunol Methods; 1982; 50(2):227-31. PubMed ID: 7045233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous and standard immune serum globulin preparations interfere with uptake of 125I-C3 onto sensitized erythrocytes and inhibit hemolytic complement activity.
    Berger M; Rosenkranz P; Brown CY
    Clin Immunol Immunopathol; 1985 Feb; 34(2):227-36. PubMed ID: 4038476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Components of human complement system. Testing and isolation of C3 and C5].
    Kosiak AV; Shukun SA; Poddubkova TN; Chikh VP; Surovtsev VI
    Biokhimiia; 1990 Feb; 55(2):276-84. PubMed ID: 2340315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional characterization of complement C4 and C1s-like molecules in teleost fish: insights into the evolution of classical and alternative pathways.
    Boshra H; Gelman AE; Sunyer JO
    J Immunol; 2004 Jul; 173(1):349-59. PubMed ID: 15210793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic complement titers and complement C3 levels in endotoxin-induced mastitis.
    Mueller R; Carroll EJ; Panico L
    Am J Vet Res; 1983 Aug; 44(8):1442-5. PubMed ID: 6354013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental bovine trypanosomiasis (Trypanosoma vivax and T. congolense). II. Serum levels of total protein, albumin, hemolytic complement, and complement component C3.
    Tabel H; Losos GJ; Maxie MG
    Tropenmed Parasitol; 1980 Mar; 31(1):99-104. PubMed ID: 7376259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplified assays of hemolytic activity of the classical and alternative complement pathways.
    Nilsson UR; Nilsson B
    J Immunol Methods; 1984 Aug; 72(1):49-59. PubMed ID: 6747305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of hemolytic complement and the third component of complement in nonhuman primates.
    Holmberg CA; Ellingsworth L; Osburn BI; Grant CK
    Lab Anim Sci; 1977 Dec; 27(6):993-8. PubMed ID: 414024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis.
    Alper CA; Colten HR; Gear JS; Rabson AR; Rosen FS
    J Clin Invest; 1976 Jan; 57(1):222-9. PubMed ID: 1107355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
    Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.